🔗 Permalink

Assignee profile:

CEL-SCI CORPORATION

City:

Vienna, Virginia

Country:

United States

Published Applications:

Last publication date:

2021-09-02

Patent Grants:

Last grant date:

2019-01-15

Top Inventors for applications by CEL-SCI CORPORATION

These are the the leading inventors for applications assigned to CEL-SCI CORPORATION:

Daniel H. Zimmerman 11 Bethesda, MD United States
Eyal Talor 4 Baltimore, MD United States
Eyal I. Talor 2 Baltimore, MD United States
Tibor Glant 1 Chicago, IL United States

Kobporn Boonnak 1 Bangkok, Thailand
Kanta SUBBARAO 1 Washington, DC United States
Geert Kersten 1 McLean, VA United States
Katalin Mikecz 1 Chicago, IL United States

Kenneth Rosenthal 1 Akron, OH United States
Kenneth Steven Rosenthal 1 Akron, OH United States
Kenneth S. Rosenthal 1 Akron, OH United States
Kobporn Boonnak 1 Silver Spring, MD United States

Harold Steiner 1 Baltimore, MD United States
Roy Carambula 1 Owings Mills, MD United States
Daniel Zimmerman 1 Bethesda, MD United States
Patricia R. Taylor 1 Medina, OH United States

Recent patent applications by CEL-SCI CORPORATION

CEL-SCI CORPORATION based in Vienna, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-09-02

US20210268101A1

Human necessities

NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-nCoV INFECTIONS

#2 | 2016-06-09

US20160158330A1

Human necessities

METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS

#3 | 2015-05-21 ✅ Patent 10,179,174 granted on 2019-01-15

US20150140065A1

Human necessities

Method for inducing an immune response and formulations thereof

#4 | 2014-09-25 ✅ Patent 10,179,164 granted on 2019-01-15

US20140286858A1

Human necessities

Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions

#5 | 2013-10-10 ✅ Patent 10,238,747 granted on 2019-03-26

US20130266599A1

Human necessities

Method for inducing an immune response against avian, swine, spanish, H1N1, H5N9 influenza viruses and formulations thereof

#6 | 2012-02-16

US20120039926A1

Chemistry; metallurgy

Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells

#7 | 2011-04-28 ✅ Patent 11,041,013 granted on 2021-06-22

US20110098444A1

Chemistry; metallurgy

Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis

#8 | 2008-03-13

US20080063625A1

Human necessities

Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine Mixture

#9 | 2007-04-03 ✅ Patent 7,199,216 granted on 2007-04-03

US10111602

Peptide constructs for treating autoimmune and related diseases

#10 | 2006-11-16

US20060257420A1

Human necessities

Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions

#11 | 2006-04-27 ✅ Patent 7,256,254 granted on 2007-08-14

US20060088544A1

Human necessities

Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions

#12 | 2006-02-07 ✅ Patent 6,995,237 granted on 2006-02-07

US10111645

Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions

#13 | 2005-10-04 ✅ Patent 6,951,647 granted on 2005-10-04

US10296317

T cell binding ligand peptides and method of inducing a cellular immune response

#14 | 2005-01-06 ✅ Patent 6,896,879 granted on 2005-05-24

US20050002896A1

Human necessities

Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture

AssigneeID:

78226 ⎘